Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-20-007640

Options or other derivatives

  • Senior VP - CMO acquired 22,600 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sheridan William P Senior VP - CMO 2020-02-21 Grant or award · Emp. Stock Option (Right to Buy) +22,600 22,600 D: show line 1 in the form
Loading xslF345X03/form4.xml…